As GSDMD-mediated pyroptosis promotes tumor infiltration and activation of CD8+ T lymphocytes (Fig. 4), we, therefore, speculated that GSDMD-dependent pyroptosis will synergize with immune checkpoint blockage therapies to potentiate anti-tumor immunity. The gene discussed is CD8A; the disease is neoplasm.